MARKER THERAPEUTICS, INC. Proceeds from (Repayments of) Related Party Debt
MARKER THERAPEUTICS, INC. (MRKR) reported Proceeds from (Repayments of) Related Party Debt of $1.79 million for the 161-month period ending 2012-12-31, per its 10-K filed 2013-05-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepaymentsOfRelatedPartyDebt · last filed 2013-05-15
- MARKER THERAPEUTICS, INC. proceeds from (repayments of) related party debt for the quarter ending 2012-12-31 was $85.22K, a 328.25% increase year-over-year.
- MARKER THERAPEUTICS, INC. proceeds from (repayments of) related party debt for the quarter ending 2012-09-30 was $60.78K, a 17.10% increase year-over-year.
- MARKER THERAPEUTICS, INC. proceeds from (repayments of) related party debt for the quarter ending 2012-06-30 was $38.64K, a 1232.55% increase year-over-year.
- MARKER THERAPEUTICS, INC. proceeds from (repayments of) related party debt for the quarter ending 2012-03-31 was $20.90K.
- MARKER THERAPEUTICS, INC. proceeds from (repayments of) related party debt for fiscal 2012 was $205.54K.
- MARKER THERAPEUTICS, INC. proceeds from (repayments of) related party debt for fiscal 2011 was -$11.40K, a 104.69% decline from fiscal 2010.
- MARKER THERAPEUTICS, INC. proceeds from (repayments of) related party debt for fiscal 2010 was $243.21K.
| Period end | Proceeds from (Repayments of) Related Party Debt 3 month | Proceeds from (Repayments of) Related Party Debt 6 month | Proceeds from (Repayments of) Related Party Debt 9 month | Proceeds from (Repayments of) Related Party Debt 12 month | Proceeds from (Repayments of) Related Party Debt 143 month | Proceeds from (Repayments of) Related Party Debt 146 month | Proceeds from (Repayments of) Related Party Debt 149 month | Proceeds from (Repayments of) Related Party Debt 152 month | Proceeds from (Repayments of) Related Party Debt 155 month | Proceeds from (Repayments of) Related Party Debt 158 month | Proceeds from (Repayments of) Related Party Debt 161 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-12-31 | $85.22K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | $146.00K derived: sum of 2 quarters · filed 2013-05-15 | $184.64K derived: sum of 3 quarters · filed 2013-05-15 | $205.54K 10-K · filed 2013-05-15 | $1.79M 10-K · filed 2013-05-15 | ||||||
| 2012-09-30 | $60.78K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $99.42K derived: sum of 2 quarters · filed 2012-11-19 | $120.32K 10-Q · filed 2012-11-19 | $140.22K derived: sum of 4 quarters · filed 2013-05-15 | $1.71M 10-Q · filed 2012-11-19 | ||||||
| 2012-06-30 | $38.64K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-12 | $59.54K 10-Q/A · filed 2012-09-12 | $79.44K derived: sum of 3 quarters · filed 2013-05-15 | $131.34K derived: sum of 4 quarters · filed 2013-05-15 | $1.65M 10-Q/A · filed 2012-09-12 | ||||||
| 2012-03-31 | $20.90K 10-Q · filed 2012-05-21 | $40.80K derived: sum of 2 quarters · filed 2013-05-15 | $92.70K derived: sum of 3 quarters · filed 2013-05-15 | $95.60K derived: sum of 4 quarters · filed 2013-05-15 | $1.61M 10-Q · filed 2012-05-21 | ||||||
| 2011-12-31 | $19.90K derived: 10-K 12 month − 10-Q 9 month · filed 2013-05-15 | $71.80K derived: sum of 2 quarters · filed 2013-05-15 | $74.70K derived: sum of 3 quarters · filed 2013-05-15 | -$11.40K 10-K · filed 2013-05-15 | $1.59M 10-K · filed 2012-04-16 | ||||||
| 2011-09-30 | $51.90K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-19 | $54.80K derived: sum of 2 quarters · filed 2012-11-19 | -$31.30K 10-Q · filed 2012-11-19 | $70.53K derived: sum of 4 quarters · filed 2012-11-19 | $1.57M 10-Q · filed 2011-11-21 | ||||||
| 2011-06-30 | $2.90K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-12 | -$83.20K 10-Q/A · filed 2012-09-12 | $18.63K derived: sum of 3 quarters · filed 2012-09-12 | $29.93K derived: sum of 4 quarters · filed 2012-09-12 | $1.52M 10-Q · filed 2011-08-22 | ||||||
| 2011-03-31 | -$86.10K 10-Q · filed 2012-05-21 | $15.73K derived: sum of 2 quarters · filed 2012-05-21 | $27.03K derived: sum of 3 quarters · filed 2012-05-21 | ||||||||
| 2010-12-31 | $101.83K derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-16 | $113.13K derived: sum of 2 quarters · filed 2012-04-16 | $243.21K 10-K · filed 2012-04-16 | ||||||||
| 2010-09-30 | $11.30K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-21 | $141.38K 10-Q · filed 2011-11-21 | |||||||||
| 2010-06-30 | $130.08K 10-Q · filed 2011-08-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |